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Purpose: The aim of this prospective study was to evaluate whether blending two kinds of biomaterials, chitosan and
polycaprolactone (PCL), can be used as scaffold and carrier for growth and differentiation of corneal endothelial cells
(CECs).
Methods: A transparent, biocompatible carrier with cultured CECs on scaffold would be a perfect replacement graft. In
the initial part of experiment, for essential and biocompatible test, chitosan and PCL were evaluated respectively and
blended in various proportions by coating. In the later part of this study, for evaluation of potential application, homogenous
solutions of 25%, 50%, and 75% PCL compositions were attempted to structure blend membranes.
Results: Chitosan, PCL 25, PCL 50, and PCL 75 blends could maintain transparency of culturing substrata. BCECs were
found to be reached confluence successfully after 7 days on PCL 25, PCL 50, and PCL 75. The expression of tight junction
and extracellular matrix protein were observed as well. Alternatively, only PCL 25 could make blend membrane with
enough strength during preparation for carrier in culture. On this blend membrane, the growth pattern and phenotype of
BCECs could be observed well.
Conclusions: A ratio of 75:25 (chitosan:PCL) blends showed enough mechanical properties as well as suitable support
for cellular activity in cultivating BCECs. Thus, a novel methodology of biodegradable carrier from chitosan and PCL
has potential to be a good replacement scaffold for raising CECs for clinical transplantation.
Corneal disease is the major cause of blindness. Over 10
million individuals experience corneal blindness worldwide
[1]. Currently, corneal transplantation is the only treatment for
restoring vision. Among the performed tissue transplants in
the US, corneal grafts are the most common with more than
50,000 annually. Moreover, 150,000 or so corneal transplants
are performed yearly in the world. Although the successful
rate of total corneal transplantation is more than 90% at 1 year
and 70% at 5 years, the penetrating keratoplasty for corneal
endothelial dysfunction is not risk free [2]. The shortcomings
of  corneal  transplantation  include  the  possibilities  of
infections, immunological rejection (increase to 25% by 4–5
years), and most important of all, insufficient donor corneas
[3].  Additionally,  increased  laser-assisted  in  situ
keratomileusis (LASIK) surgeries have also diminished the
supply of healthy donor tissue. Up to date, still millions of
patients  around  the  world  have  need  of  corneal
transplantation.
The human corneal endothelial cells (HCECs) originate
from neural crest and cover the posterior surface of cornea as
a  monolayer.  They  maintain  corneal  transparency  by
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regulating corneal hydration through its pump and barrier
functions [4]. When they loss due to dystrophy, trauma, or
surgical  intervention,  a  compensatory  enlargement  of  the
remaining cells followed and resulted in irreversible corneal
endothelial  dysfunction.  In  these  situations,  an  alternative
method  for  replacing  the  endothelium  without  corneal
trephination  and  sutures  can  save  the  vision  of  patients.
Posterior  lamellar  keratoplasty  including  deep  lamellar
endothelial keratoplasty (DLEK) [5,6], Descemet’s stripping
endothelial  keratoplasty  (DSEK)  [7],  and  Descemet’s
stripping automated endothelial keratoplasty (DSAEK) [8]
has been developed in recent years. The advantages of these
operations are less suture-related graft complications, reduced
astigmatism,  better  visual  prognosis,  and  safer  closed-eye
surgery.  However,  the  supply  of  donor  cornea  remains
uncertain and usually makes patients wait for a long time.
Within the anterior chamber, HCECs are immersed in
aqueous humor, and cytokines such as transforming growth
factor-beta2 (TGF-β2) were illustrated to inhibit proliferation
of  HCECs  by  hampering  the  G1-to-S  transition  [4].
Furthermore, contact-dependent inhibition also plays a major
role in the induction of cell-cycle arrest [9]. Even if the human
corneal endothelium is held in a non-proliferative state within
the eye, HCECs do retain the ability to proliferate [4,9,10].
Accordingly,  one  promising  opportunity  for  relieving  the
requirement for donated cornea is the development of a tissue-
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255engineering corneal equivalent. Techniques for cultivating
HCECs have been reported [11,12], and effort has been made
to build up transplantation models of cultivated human HCEC
sheets using carriers from either natural tissue materials [13,
14] or artificial polymeric materials [15,16]. Though attempts
had been made to develop transplantation models, there are
still many problems including insufficient supply of donors
for corneal graft, cell culture drawbacks, bio-toxicity, and
biocompatibility. Therefore, new biomaterial selections are
necessitated  for  the  development  of  clinical  demands  for
corneal replacements in regenerative medicine.
In  the  field  of  bioengineered  corneal  endothelium,
discovering  an  ideal  carrier  material  has  been  always  an
important  issue.  The  perfect  cell  carriers  for  corneal
endothelial transplantation should be cellular innocuously,
biodegradable appropriately, and handle easily. This goal may
not  be  approached  by  single  biomaterial.  Blending  two
polymers  is  a  chance  to  develop  novel  biomaterials  with
combinations  of  individual  properties.  Chitosan  and
polycaprolactone  (PCL)  are  biodegradable  biomaterials
approved  by  Food  and  Drug  Administration  (FDA)  with
numerous advantages respectively. Surprisingly, the biologic,
degradation or mechanical properties of polymer blends have
disclosed  promising  results  in  comparison  to  that  on  the
separate  culturing  substratum  [17,18].  Based  on  different
characteristics  of  chitosan  and  PCL,  the  present  study
hypothesizes that it is possible to create a new blend material
that  can  combine  the  features  of  chitosan  and  PCL
concurrently to be a scaffold and carrier for CEC culture and
transplantation.
METHODS
Preparation  of  culturing  substrates:  In  the  first  part  of
experiments, chitosan (degree of deacetylation=85%; Sigma-
Aldrich, St. Louis, MO) was dissolved in 0.5 M acetic acid to
prepare 1 wt% chitosan solutions. PCL (Sigma-Aldrich) was
dissolved  in  glacial  acetic  acid  to  prepare  10  wt%  PCL
solutions. To obtain 25, 50 and 75 wt% PCL in chitosan/PCL
solutions, different volume of 10 wt% PCL solutions and
glacial  acetic  acid  were  slowly  added  to  3  ml  of  1  wt%
chitosan.  For  simplified  expression,  the  substrates  were
namely chitosan, PCL 25, PCL 50, PCL75, and PCL 100
according  to  PCL  proportion.  Then  culturing  plates  were
prepared by coating polymer solution onto 6- or 24-well tissue
cultured polystyrene (TCPS; Costar, Corning, NY) directly.
After 30 min of incubation at room temperature, the solutions
were removed and the wells were dried in a convection oven
at 55 °C for 24 h. The prepared substrates were neutralized in
0.5 N NaOH aqueous solutions for 24 h and were then washed
thoroughly with deionized water. Before cell culturing, the
coated and uncoated wells were exposed to ultraviolet light
overnight.
Measurement of transparency and transmittance: Substrates
were  prepared  in  60  mm  TCPS  (Costar)  to  determine
transparency. The plates were then placed on the graph paper
and transparency of the prepared substrates was photographed
by a digital camera. The transparency was also quantified by
determining light transmittance of the membrane by a home-
built device. In brief, the initial illumination from a white light
source was measured by a digital lux meter (MLM-1010;
minipa®, Sao Paulo, Brazil). Initially, a blank TCPS plate,
serving as the control, was inserted between the light source
and the digital lux meter at 100% transmittance. After that,
chitosan,  PCL  25,  PCL  50,  PCL  75,  and  PCL  100  were
inserted respectively and illumination was measured again.
Transmittance ratio is defined as the value of the prepared
substrates relative to that of the blank TCPS plate.
Primary culture of BCECs: This animal study was performed
in line with an animal use protocol approved by the Review
Committee of Taipei Medical University. Fresh bovine eyes
were acquired from the local abattoir and immersed in iodine
solution for 3 min, then transferred into phosphate-buffered
saline (PBS; Invitrogen, Carlsbad, CA). As a modification
from  previous  studies  [19,20],  fresh  bovine  corneal
endothelial sheets were peeled and digested by trypsin in
37 °C for 30 to 60 min. Next, endothelial cells were collected
by centrifugation of the supernatant (750× g for 5 min). Cell
culture  was  performed  in  the  supplemented  hormonal
epithelial  medium  (SHEM),  which  is  composed  of  equal
volumes  of  HEPES-buffered  DMEM  and  Ham  F12
(Invitrogen)  supplemented  with  5%  FBS,  0.5%  dimethyl
sulfoxide (Sigma-Aldrich), 2 ng/ml hEGF (Sigma-Aldrich), 5
ug/ml  insulin,  5  ug/ml  transferrin,  5  ng/ml  selenium
(Invitrogen), 1 nM cholera toxin (Sigma-Aldrich), 50 μg/ml
gentamicin  (Invitrogen),  and  1.25  μg/ml  amphotericin  B
(Invitrogen).  The  flask  was  incubated  at  37  °C  in  an
atmosphere  of  95%  air/5%  CO2.  When  cells  reached
confluence  after  14–21  days,  they  were  rinsed  in  PBS,
detached by trypsinization with 0.05% trypsin for 5 min at
37 °C, and spun down. The cells were then suspended into
SHEM.  Subsequently,  about  50,000  cells  in  each  24-well
culturing plate were loaded and maintained in a humidified
atmosphere with 5% CO2 at 37 °C. The media was changed
every 2 to 3 days for up to 7 days in SHEM. The morphology
of cells was viewed under a phase contrast microscope (Leica,
Wetzlar, Germany).
Immunohistochemistry: BCECs on culturing substrates and
blend membranes were fixed at indicated time points by 4%
fresh  buffered  paraformaldehyde  (pH  7.4)  at  room
temperature for 30 min. After being blocked with 10% BSA
containing 0.5% Triton-X at room temperature for 1 h, cells
were incubated overnight at 4 °C with a 1:200 dilution of anti-
ZO-1 (Millipore, Temecula, CA). After washing twice with
PBS for 15 min, samples were incubated with a 1:100 dilution
of  Alexa  Fluor  568-conjugated  secondary  antibodies
(Invitrogen) at room temperature for 1 h. For observing actin
cytoskeleton  BCECs  on  PCL  25  membrane,  Alexa-Fluor
phalloidin  546  secondary  antibodies  were  used  to  stain
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DAPI (1:5000; Invitrogen) at room temperature for 5 min.
After several washes, all samples were mounted in fluorescent
mounting  solution  (VectA  Mount;  Vector  Laboratories,
Burlingame, CA). Immunofluorescent images were obtained
using Zeiss Axiovert 200 inverted microscope (Carl Zeiss,
Jena,  Germany)  or  Leica  TCS  SP5  confocal  spectral
microscope imaging system (Leica).
Western blot analysis: Western blot analysis for collagen type
IV expression of BCECs after being cultured on different
substrates for 7 days was performed in standard protocols. In
brief, proteins from cell extracts were separated by sodium
dodecyl  sulfate  PAGE  (SDS–PAGE)  on  8%  Tris-HCl
reducing  gels,  transferred  to  PVDF  membrane  (Bio-Rad,
Hercules, CA), and blocked with blocking solution overnight.
Collagen  type  IV  expression  was  detected  by  using  goat
antibody  against  collagen  type  IV  (1:1000;  Millipore)  or
mouse  anti-β-actin  (1:10,000;  Invitrogen),  followed  by
appropriate secondary antibodies (rabbit anti-goat, 1:10,000;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA) conjugated
with  horseradish  peroxidase.  Immunoreactive  bands  were
visualized  with  an  enhanced  chemiluminescence  (ECL;
Perkin-Elmer Life Science, Boston, MA) system. The results
were also presented as the ratio of collagen type IV expression
of BCECs on chitosan/ PCL blends relative to that on chitosan.
Preparation of chitosan and PCL blend membranes: In the
second  part  of  the  experiments,  chitosan  and  PCL  blend
membranes were prepared by mixing 75:25 (PCL 25), 50:50
(PCL 50), 25:75 (PCL 75; wt% of chitosan with wt% of PCL),
respectively. The mixture of chitosan and PCL polymer was
dissolved by formic acid in 5 wt%. Polymer solutions were
coating on glass plate, and then evaporated in a convection
oven at 55 °C over 24 h. The nascent membranes on glass plate
were placed in 0.5 N NaOH until the membranes detached
from the glass plate. Prevented from splitting and dryness,
prepared membranes were then placed in 10 cm glass plate
with PBS. The plates were then placed with black background
and  photographed  by  a  digital  camera.  However,  when
preparing for cell culture, only pure chitosan and PCL 25 (75
wt% of chitosan with 25 wt% of PCL) can make membranes
with enough strength successfully. The PCL 50 and PCL 75
membranes were fragile easily. Subsequently, the residual
solvent in the chitosan and PCL 25 membranes was removed
by a series of washing steps. Finally, those membranes were
cut in size to fit 6- or 24-well TCPS, and sterilized with 70%
alcohol  under  ultraviolet  light  overnight  and  then  rinsed
extensively with PBS before usage. Chitosan and PCL 25
membrane in 6-well TCPS size placed on the vision screen
chart  and  transparency  of  the  prepared  membranes  was
photographed by a digital camera.
Seeding  of  BCECs  on  PCL  25  membrane:  Passage  2–3
confluent, subcultured cells derived from fresh bovine eyes
were seeded onto PCL 25 membrane. The seeded cell numbers
was 50 000, and the cells were cultivated for 7 days.
Statistical analysis: All experiments were repeated at least
three times from different groups. Statistical analyses were
performed  with  SPSS  software  (SPSS  Inc.,  Chicago,  IL).
Means  were  reported  alongside  with  standard  deviation.
Comparative analysis of the results was conducted using a
two-tailed t test for western blot analysis. A p value of <0.05
or 0.01 indicated statistical significance.
RESULTS
Transparency and transmittance: The cornea is the outermost
window  in  the  visual  pathway,  optical  transparency  of
implanted biomaterials is also important for vision. During
CEC  culture  and  transplantation,  transparent  membranes
enable observation of cell behavior, healing process and signs
of  possible  infection.  Therefore,  transparency  of  prepared
membranes is significant for clinical applications [21]. The
result is shown in Figure 1A. The graph paper was clearly
observed through the empty TCPS. In the experimental group,
the  lines  on  the  graph  paper  were  easily  viewed  through
chitosan,  PCL  25,  PCL  50,  and  PCL  75,  indicating  that
chitosan  blended  with  25%,  50%  and  75%  of  PCL  still
preserved  transparency.  However,  the  substratum  became
opaque in pure PCL (PCL 100) and the lines on the graph
paper could hardly be traced, indicating that this sample was
not  transparent.  Quantitatively,  a  similar  diminishing
transmittance through PCL 100 was measured when it was
compared  with  chitosan  and  other  blends  (Figure  1B).
Therefore, BCEC culture was not performed on PCL 100 in
the following experiments.
Cell  morphology  of  cultured  BCECs  on  the  culturing
substrates: Figure 2A illustrated BCEC morphology on the
blends after 7 days by phase contrast microscope. BCECs
adhered on chitosan but appear dispersed. On PCL blends
(PCL 25, PCL 50, and PCL 75), BCECs spread well and
reached confluence. Moreover, immunofluorescent staining
of  cultured  BCECs  on  the  culturing  substrates  showed
expression  of  tight  junction  marker,  ZO-1  protein,  at  the
margin of cells. ZO-1 is a tight-junction-associated protein
located  in  the  CEC  monolayer  [19,20].  These  findings
confirmed the physiologic phenotypes of BCECs cultured on
PCL 25, PCL 50, and PCL 75 substrates after 7 days of
incubation (Figure 2B). With increasing PCL content, the
expression patterns seem to become more obvious in PCL 50
and PCL 75. On the other hand, expression of ZO-1 in BCECs
cultured  on  chitosan  was  not  prominent  at  cell  junction
indicated that BCECs did not develop to the terminal stage
morphology present in typical cells.
Collagen type IV production: To determine whether blends
were able to stimulate BCECs increasing extracellular matrix
(ECM) protein production, the amount of collagen type IV of
BCECs cultured on chitosan, PCL 25, PCL 50, and PCL 75
after  7  days  of  incubation  was  assessed  by  western  blot
analysis. On all culturing substrates, expressions of collagen
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257Figure 1. The transparency and light transmittance of the prepared culturing substrates. A: The lines of graph paper could be easily seen
through chitosan, PCL 25, PCL 50, and PCL 75. As for PCL 100, it is remarkable that the prepared culturing substrate became opaque. B:
The light transmittance decreased particularly through PCL 100.
Molecular Vision 2012; 18:255-264 <http://www.molvis.org/molvis/v18/a29> © 2012 Molecular Vision
258Figure 2. Cultivation of BCECs on chitosan and the blends. A: The morphological changes in BCECs cultured on chitosan, PCL 25, PCL 50,
and PCL 75 after culture. At day 7, BCECs reached confluence in PCL 25, PCL 50 and PCL 75 groups. B: The expressions of ZO-1 (green)
of BCECs cultured on chitosan, PCL 25, PCL 50, and PCL 75 after 7 days of incubation. Scale bar=100 µm.
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expression of β-actin, Figure 3B showed the production of
collagen type IV by BCECs on blends was significantly higher
than  that  on  chitosan.  By  comparing  with  the  amount  of
collagen type IV production on chitosan, the ratio on blends
was 1.28 in PCL 25 (p=0.003), 1.20 in PCL 50 (p=0.04), and
1.24  in  PCL  75  (p=0.02),  respectively.  These  findings
indicated  that  blends  were  presumably  collagen  type  IV
stimulants  in  BCECs.  Furthermore,  BCECs  cultured  on
PCL25 had the highest production of collagen type IV in this
study.
The macroscopic features of blend membranes: The mixture
of chitosan and PCL polymer solutions were dried at 55 °C
(near the PCL melting point) in the oven. Membranes, which
formed  and  detached  from  glass  plate,  were  highly
homogeneous in structure and had a distinctive morphology.
Avoided  from  splitting  and  dryness,  prepared  membranes
were taken photographs by digital camera in 10 cm glass plate
full under wet conditions with PBS (Figure 4A). Obviously,
increased  PCL  component  diminished  the  transparent
character of chitosan membrane. These membranes were tried
to cut in size to fit 24-well TCPS for culture. Nevertheless,
PCL  50  and  PCL  75  were  fragile  and  with  difficulty  to
fabricate carrier membranes. Only pure chitosan and PCL 25
(75 wt% of chitosan with 25 wt% of PCL) membranes had
enough strength. Chitosan and PCL 25 membrane were then
cut out in size of 6-well TCPS plate. Figure 4B illustrated the
transparency of both membranes. The number “5” on the
vision screen chart could be easily visualized.
Cell  morphology  and  phenotype  expression  of  cultured
BCECs  on  PCL  25  blend  membrane:  Although  chitosan
membrane  could  be  prepared,  the  growth  and  phenotype
expression of BCECs were not superior to those on blends in
the previous experiments. We only cultivated BCECs on PCL
25  blend  membrane.  By  means  of  confocal  microscope,
Figure 5A demonstrated BCEC cytoskeleton with well spread
pattern on PCL 25 blend membrane at day 7. In addition, ZO-1
protein expression was confirmed at the margin of cells in
Figure 5B. These findings might also imply that this carrier
material did not cause cytotoxicity.
DISCUSSION
For  biodegradable  biomaterials,  chitosan  is  a  linear
polysaccharide with a changeable number of randomly placed
N-acetyl-glucosamine  groups.  It  is  formed  from  fully  or
partially  deacetylated  chitin,  which  is  the  second-most
abundant polymer in nature. Chitosan has been extensively
applied in tissue engineering because of its biocompatibility,
Figure 3. The effects of the blends on
expression  of  collagen  type  IV  in
cultivated  BCECs.  A:  Western  blot
analysis of anti- collagen type IV and
anti-β-actin  in  BCECs  cultured  on
chitosan, PCL 25, PCL 50, and PCL 75
after  7  days  of  incubation.  Increased
expression  of  type  IV  collagen,  a
corneal endothelial cell marker, with a
molecular  weight  of  160  KDa  was
clearly observed in BCECs cultured on
blends.  B:  The  relative  intensities  of
collagen type IV level were determined
by band densitometry analysis. The ratio
of the band intensities was expressed as
a percentage of chitosan. Results were
expressed  as  mean±SD  from  three
independent  experiments  (*p<0.05  or
**p<0.01).
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260biodegradability,  non-antigenic  effect,  wound  healing
properties,  and  low  costs  [22].  It  can  also  promote  ECM
fabrication  [23,24].  Despite  these  advantages,  its  current
usage in tissue engineering is limited mainly because of low
strength and incomplete understanding of cellular interactions
with chitosan. Nevertheless, several approaches have been
taken to overcome the restrictions of chitosan, including graft
polymerization [25,26] and blending [27,28]. Surprisingly,
the biologic, mechanical or degradation properties of polymer
blends have revealed promising results in comparison to that
Figure 4. The appearance of the blend membranes formed by dry process. A: Macroscopic view of the blended membranes and placed in glass
plate under wet conditions with PBS. B: The appearance of chitosan and PCL 25 membrane after cutting out in size of 6-well TCPS plate and
placed on vision screen chart.
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261on the separate culturing substratum. Alternatively, PCL, a
flexible synthetic polymer with low melting point (60 °C),
allows for easy processing and is therefore a suitable selection
for  blending.  Additionally,  it  is  biodegradable  and
biocompatible  polyester  with  excellent  tensile  properties
[17].  Nevertheless,  a  major  drawback  of  PCL  is  reduced
bioregulatory activity primarily in tissue engineering; this is
because  of  its  hydrophobic  nature  and  slow  rate  of
biodegradation. However, the flexibility of PCL in blending
with other polymers allows the adjustment of its properties to
overcome its drawbacks [17].
According to Williams [29], a biomaterial is “a substance
that has been engineered to take a form which, alone or as
part of a complex system, is used to direct, by control of
interactions with components of living systems, the course of
any  therapeutic  or  diagnostic  procedure,  in  human  or
veterinary medicine.” Native corneal endothelium is a densely
packed monolayer of regular hexagonal cells boarding the
posterior aspect of the cornea [4]. From the perspective of
CEC  tissue  engineering,  a  successful  biomaterial  should
support  cells  to  adhere,  proliferate,  and  execute  their
physiologic  function.  Both  chitosan  and  PCL  have  been
approved by FDA as biodegradable biomaterials. Without
complex  chemical  modification,  blending  hydrophilic
chitosan  and  hydrophobic  PCL  can  be  achieved  and
represented as a good model for two semicrystalline polymers
[17,18]. On chitosan and PCL blends, cells can modulate gene
expression and produce collagen through cell shape changes
[18]. Hence, based on different adhesion effects on chitosan
and PCL, the present study is focused on the behavior of CECs
on chitosan and PCL blends.
In the initial part of this test, the BCECs were cultured on
a series of chitosan and PCL blends. Appropriate transparency
cannot be maintained on pure PCL (Figure 1A,B). As for
transmittance, the transparency of the biomaterial membranes
is advantageous for clinical application. Although chitosan
could not support CEC adhesion entirely, polymer blending
can  effectively  change  the  properties  of  a  biomaterial.
Nevertheless, due to poor transparency, PCL 100 was not used
in the subsequent experiments. For cell observation during
culture, pure chitosan, PCL 25, PCL 50 and PCL 75 substrates
were  directly  observed  under  inverse  phase  contrast
microscope. On chitosan and PCL blends, BCECs reached
confluence in 7 days (Figure 2A). The results obtained from
chitosan  substrate  were  inconclusive.  In  addition  to  cell
morphology, expression of tight junction ZO-1 was used to
confirm  the  cultured  BCECs  without  changing  their
phenotype  on  the  substrata  during  culture.  Likewise,  the
expression patterns of ZO-1 were not observed in cultured
BCECs on chitosan, indicating BECEs did not develop to its
mature morphology (Figure 2B). In contrast, when BCECs
were cultured on PCL 25, PCL 50, and PCL 75, the expression
of tight junction ZO-1 was well developed, resembling ideal
physiologic  phenotypes  [19,20].  In  the  long  term  cellular
responses  on  biomaterials,  endogenous  ECM  proteins
synthesized by cells are crucial for cell activities. For instance,
CECs can synthesize collagen type IV which is deposited and
specifically found in their basement membrane. Also, Tseng
et al. [14] have reported that specific ECM proteins, collagen
type IV, can be produced by cultured CECs when they reach
confluence. In agreement with the concept that the culture
system used for tissue engineering should be bioactive, the
biomaterial which is capable of simulating endogenous ECM
production is always preferable [14]. As shown in Figure 3,
western  blot  analysis  demonstrated  that  the  amount  of
collagen type IV production of BCECs cultured on blends was
greater than that on chitosan. On the other hand, we performed
western  blotting  for  type  I  collagen,  which  represented  a
fibrosis marker of CECs according to previous studies [30].
The expressions of collagen I demonstrated extremely few on
the blends (data not shown). For that reason, TGF-beta/Smad
signals may be related to corneal endothelial fibrosis. The cell
activity  and  signaling  between  CECs  and  blends  will  be
worthy  further  surveyed.  Therefore,  these  results  further
Figure  5.  Immunohistochemistry  of
cultured  BCECs  on  PCL  25  blend
membrane.  A:  The  expressions  of
cytoskeleton actin filament of BCECs at
day  7  by  confocal  microscope.  B:
Correspondingly,  the  expressions  of
ZO-1 (green) at the margin of cells after
7 days. Scale bar=50 µm.
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surface characteristics of biomaterials.
In the subsequent part of this investigation, we made
effort in preparation of blend membrane from a single phase
solution. Since chitosan has relative low break stress and
elastic  modulus,  blending  with  PCL  would  provide  an
opportunity to create a material with proper tensile properties.
The membranes fabricated from homogenous solution with
different proportions of chitosan and PCL by dry process were
shown in Figure 4A. Nevertheless, homogenous solution of
PCL 50 and PCL 75 produced very brittle membranes. This
could be explained by the highly crystalline nature of PCL.
For  potential  application  in  corneal  endothelial
transplantation, membranes had to be cut out in desired size.
Chitosan  and  PCL  25  blend  membrane  were  successfully
generated with optical clarity after drying (Figure 4B). We
cultivated BCECs on PCL 25 membrane because they could
not adhere and proliferate well on chitosan in the previous
experiments.  Captured  images  by  confocal  microscopic
system  in  Figure  5,  cultured  BCECs  on  PCL  25  blend
membrane  spread  out  well  and  displayed  physiologic
phenotype of ZO-1. These results suggested that PCL 25 blend
membrane was able to support the function of the BCECs in
vitro. The major findings in these experiments illustrated that
blending  chitosan  with  PCL  successfully  allowed  cell
adherence, improved phenotypic expressions, and maintained
transparency. In a specific proportion, blend membrane was
fabricated  to  be  a  scaffold  and  carrier  with  sufficient
mechanical strength. As compared to manufacture of other
carriers, our PCL blend membrane could be prepared easily
without complex processing. Since our final goal is to develop
carrier sheet, the establishment of animal model for corneal
endothelial  transplantation  may  be  required  in  the  future
studies.
Conclusions—In the first part of experiment, hydrophilic
chitosan was blended successfully with hydrophobic PCL in
homogenous  solutions  without  complex  chemical
modification. Transparency could be maintained in chitosan
and  PCL  blends  as  well.  Furthermore,  BCECs  reached
confluence and expressed tight junction and ECM proteins on
blends. In the later part of research, only 75:25 (chitosan:
PCL) could make blend membrane with enough strength for
scaffold  and  carrier  in  culture.  On  this  blend  membrane,
BCECs  could  expand  and  grow  well.  Therefore,  novel
chitosan and PCL blend membrane to be a biomaterial may
provide the opportunity for surveying further transplantation
of bioengineered corneal endothelium.
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